[Radionuclide therapy of malignant and benign extra-thyroid diseases].
Basis, indications and results of the endolymphatic therapy with radionuclides, of the selective therapy with radiophosphorus and radiostrontium and of the intraarticular and endocavitary therapy with radiocolloids are described. Future scientific engagement and intensive basic research in radionuclide therapy is required. However, because of the expected therapeutic profit the efforts seem to be justified.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000532:radiotherapy; D002648:Child; D002675:Child, Preschool; D005260:Female; D006048:Gold Colloid, Radioactive / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000532:radiotherapy; D010534:Peritoneal Neoplasms / Q000532:radiotherapy; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000532:radiotherapy; D011868:Radioisotopes / Q000627:therapeutic use*; D011878:Radiotherapy / Q000379:methods*; D011879:Radiotherapy Dosage
D006048:Gold Colloid, Radioactive; D007457:Iodine Radioisotopes; D010761:Phosphorus Radioisotopes; D011868:Radioisotopes
Radionuklidtherapie maligner und benigner Erkrankungen ausserhalb der Schilddrüse.